Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Wolfe Research warns that while the second half of 2026 is unlikely to bring sweeping policy overhauls, a sequence of congressional deadlines, tariff shifts, regulatory rulemakings and geopolitical events could materially influence sectors from manufacturing and healthcare to financials and energy. Key items include government funding before Oct. 1…
BofA Securities interprets the recent pullback in Japan's AI-linked equities as a constructive rotation across markets rather than the start of a wider downturn. The bank points to concerns around data center spending sustainability, rising memory and AI token costs, and momentum shifts toward cheaper Chinese open-source models. It recommends maint…
Russian equities closed lower on Sunday with mixed individual stock performances and the MOEX Russia Index unchanged at the close while registering a new three-year low. Energy and some banking shares were among the session's top performers, while miners and selected blue-chips underperformed. Volatility on MOEX options rose to a six-month high as …
Silence (SLN) trades at a market cap of ~$429M and is a candidate for a meaningful re-rating if upcoming polycythemia vera (PV) data and continued RNA-platform progress validate the program. We initiate a long trade with a clear entry, stop and a long-term target that still sits well below many analyst 12-month averages.
Disney trades near its 52‑week low despite healthy free cash flow, low leverage and multiple near‑term catalysts (summer parks, new theatrical releases). At roughly $95.73 today, the stock looks like a mid‑term buy: entry $95.73, stop $91.50, target $110.00 over ~45 trading days.
Biogen and Eisai presented clinical data at AAIC 2026 demonstrating that LEQEMBI® (lecanemab) subcutaneous autoinjector (SC-AI) provides comparable efficacy and safety to the intravenous (IV) formulation for treating early Alzheimer's disease. The SC formulation offers a convenient, flexible dosing option that may enhance patient access and adheren…
SanDisk is reinventing itself from a pure NAND supplier into a vertically integrated, product-led storage company aimed at enterprise AI, edge compute and automotive. The market is still treating it like a commodity play. This trade buys that the re-rating of margins and recurring-software revenue is coming into the price over the next 180 trading …
UBS Asset Management remains constructive on global equities, pointing to resilient economic growth, widening corporate earnings and supportive earnings momentum tied to AI. The firm warns, however, that persistent U.S. core inflation could keep the Federal Reserve on a hawkish trajectory, which would bolster the dollar, pressure bond returns and i…
Nvidia told investors its data-center product roadmap is intact and that demand for AI infrastructure is strong across hyperscalers, enterprises, sovereign customers and startups. The company confirmed production use of co-packaged optics with Spectrum-X, noted upcoming choices in interconnects beginning with the Feynman platform in 2028, and reite…
Goldman Sachs cautions that a stronger-than-expected U.S. inflation print this week could shift market expectations for Federal Reserve tightening and put downward pressure on equities, even as the bank expects another quarter of solid corporate earnings. Goldman projects June core inflation to rise 0.17% month-on-month and headline inflation to fa…
BridgeBio's recent clinical readouts and a $1 billion preferred equity infusion materially de-risk the company's near-term cash runway while multiple NDA submissions and Attruby's strong long-term mortality signal justify a
Evaxion A/S presented encouraging preclinical data for its cytomegalovirus vaccine candidate EVX-V1, developed using its AI-Immunology™ platform. The multi-component vaccine combines novel AI-discovered antigens with optimized established CMV vaccine antigens to potentially enhance protection against acute infection, latency, and viral reactivation…
Evercore's upgrade to outperform and a cleaner balance sheet give Occidental (OXY) a credible path to re-rating. Free cash flow, modest leverage and strong EV/EBITDA metrics argue for further analyst upgrades and short-covering. This is a tactical long trade for the mid term (45 trading days) with clear risk controls.
Cybin (HELP) is a clinical-stage psychedelic drug developer trading at $6.86 with a $425M market cap. Technical momentum, a shrinking 52-week range, and concentrated short interest create a favorable asymmetric setup ahead of upcoming clinical catalysts. This trade idea targets a mid-term swing (45 trading days) long entry on a pullback, with clear…
U.S. equities enter a busy week where a slate of economic readings, the start of second-quarter earnings and heightened Iran-related tensions will influence investors already navigating sizable sector swings beneath the surface of broadly firm indexes. Key items include Tuesday's consumer price index, bank results from JPMorgan Chase and Goldman Sa…
Saudi Arabia's main exchange finished the session marginally higher, with the Tadawul All Share up 0.10%. Strength in industrial investment, cement and building and construction-related names powered advances among the best performers, while select energy and refinery-linked stocks led declines. Commodity markets saw crude, Brent and gold prices sl…
Palestinian health officials reported that Israeli strikes on Sunday killed at least three people in the Gaza Strip, including a 9-year-old girl killed by gunfire at a tent encampment in Al-Bureij and two people killed in an airstrike on a metal foundry in Gaza City's Sabra neighbourhood. Israel's military said it had targeted "terrorist" infrastru…
SEI Investments (SEIC) is trading at $95.45 with a 15.6x P/E, strong profitability (ROE ~30%), low leverage (debt/equity 0.07) and $634M in free cash flow. Technicals show momentum above the 10/20/50-day averages and short interest is modest. If flows tied to small-cap index rebalancing materialize, SEIC is well positioned to catch a squeeze. This …
Argan (AGX) is a niche engineering and construction play benefiting from a surge in data-center and grid-related power work. With a $2.9 billion backlog, robust free cash flow, and zero net debt, the company has visibility into 2026-2027 revenue and margin expansion. The technical pullback creates an actionable entry with a tight stop-loss and a co…
Iraq’s prime minister will visit Washington on Monday to deepen strategic ties with the United States. Multiple memorandums of understanding in the oil and gas sector are expected to be signed, aimed at bringing U.S. firms into projects that could help raise production capacity. The agreements also aim to develop alternative export outlets to lower…
Frontline's tanker franchise is cashing in on tighter tonnage and geopolitical uncertainty. With a $1.55 quarterly distribution already paid and P/E under 10, the stock offers an attractive risk/reward headed into the summer trading window. We keep a Strong Buy and lay out an explicit entry, stop and target for a mid-term swing trade.
Five major analyst calls this week lifted coverage on T-Mobile US, First Solar, Occidental Petroleum, Five Below and Toll Brothers. The upgrades, from BofA, Deutsche Bank, Evercore, Mizuho and Citi respectively, emphasize differing rationales: defensive urban positioning and pricing power for T-Mobile; a deep valuation gap and cash cushion at First…
Egypt recorded a current account deficit of $5.1 billion in the first quarter of 2026, up from $2.3 billion a year earlier, central bank data show. The larger shortfall was driven mainly by an expanded merchandise trade deficit and was partially mitigated by stronger remittances, tourism income and Suez Canal receipts. Net foreign direct investment…
Hemab Therapeutics presented new clinical data demonstrating HMB-002's proof of mechanism in elevating Von Willebrand Factor and Factor VIII levels in patients with Von Willebrand Disease, supporting potential monthly subcutaneous dosing. The company also introduced HMB-003, a novel non-hormonal antifibrinolytic drug targeting heavy menstrual bleed…
Sheikh Hamad bin Khalifa Al-Thani, who guided Qatar through a period of rapid economic expansion and elevated its diplomatic profile, died on Sunday at the age of 74. Authorities have not disclosed the cause of death. His rule from 1995 to 2013 saw major growth in LNG production and export capacity, international media initiatives, deep infrastruct…
